Zenapax (Humanized Antibody Against The IL-2 Receptor Alpha Chain) As A Novel Treatment For Multiple Sclerosis
Technology
E-143-2002
Patent ID
E-143-2002-1-US-77
Country
US
Application Type
CON
Patent Status
Abandoned
Patent Number
Publication Number
US-2018-0237532
Application Number
15/956,458
IC
NINDS
Date Filed
Date Issued
Patent PDF